Primary pulmonary Hodgkin lymphoma (PPHL) is a rare disease. Herein, we report a case of PPHL with diagnostic concerns encountered during initial evaluation which is of paramount importance to keep the differential diagnosis in cases with high index of suspicion for this rare entity.

Neoadjuvant therapy now becomes a surgical tool in management of breast cancer. A documented benefit of neoadjuvant therapy is downstaging of the disease allowing for BCS in approximately one-quarter of patients initially planned for mastectomy.Retrospective study was obtained from 75 female patients with nonmetastatic breast cancer who are admitted in the Alexandria Main University hospital, surgical oncology unit.